HSIC - Henry Schein Inc Stock Analysis

Henry Schein Inc (HSIC) is a publicly traded company listed on the NASD. It operates in the Medical Distribution industry, part of the broader Healthcare sector. The company has a market capitalization of 8.58B, generates annual revenue of 12.94B, and reports net income of 391.00M. As of the latest data, the stock is trading at 72.86 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. This stock does not currently pay a dividend. The stock has average market volatility, aligning with general market movement.

Analyst recommendation stands at Hold (3.59), indicating current market sentiment. Institutional ownership is reported at 98.79%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -2.19%, trading within a 52-week range of 60.56 - 82.49.

HSIC - Henry Schein Inc

72.86
Analyst Consensus
Hold 3.59
HSIC – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 4
  • Buy: 7
  • Hold: 9
  • Sell: 2
  • Strong Sell: 0
  • Total Analysts:  22

Last update: 2025-12-09 04:37:46
Index: S&P 500 P/E: 23.02 EPS (ttm): 3.17 Insider Own: 16.00% Shs Outstand: 118.57M Perf Week: -0.34%
Market Cap: 8.58B Forward P/E: 13.80 EPS next Y: 5.28 Insider Trans: 0.05% Shs Float: 98.89M Perf Month: 4.00%
Income(ttm): 391.00M PEG: 3.15 EPS next Q: 1.30 Inst Own: 98.79% Short Float: 7.19% Perf Quarter: 7.70%
Revenue(ttm): 12.94B P/S: 0.66 EPS this Y: 3.53% Inst Trans: -4.87% Short Ratio: 4.68 Perf Half Y: 2.76%
Book/sh: 28.35 P/B: 2.57 EPS next Y: 7.61% ROA: 3.60% Short Interest: 7.11M Perf Year: -2.19%
Cash/sh: 1.16 P/C: 63.07 EPS next 5Y: 7.30% ROE: 11.39% 52W Range: 60.56 - 82.49 Perf YTD: 5.29%
Dividend Est.: - P/FCF: 21.28 EPS past 3/5Y: -11.48% -2.15% ROIC: 6.77% 52W High: 82.49 -11.67% Beta: 0.89
Dividend TTM: - Quick Ratio: 0.79 Sales past 3/5Y: 0.73% 4.88% Gross Margin: 29.20% 52W Low: 60.56 20.31% Perf 5Y: 12.25%
Dividend Ex-Date: - Current Ratio: 1.40 EPS Y/Y TTM: 29.65% Oper. Margin: 5.99% RSI (14): 55.69 Volatility: 1.90% 2.05%
Employees: 25000 Debt/Eq: 1.02 Sales Y/Y TTM: 3.51% Profit Margin: 3.02% Recom: 2.50 Target Price: 77.64
Option/Short: Yes / Yes LT Debt/Eq: 0.72 EPS Q/Q: 7.10% Payout: 0.00% Rel Volume: 0.69 Prev Close: 73.62
Sales Surprise: 1.92% EPS Surprise: 8.06% Sales Q/Q: 5.20% Earnings: Nov 04 BMO Avg Volume: 1.52M Price: 72.86
SMA20: -0.10% SMA50: 6.76% SMA200: 5.30% Undervalued: 6.56%
Volume: 1,041,623 Change: -1.03%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Henry Schein Inc

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2025 www.stocks-expert.com All Rights Reserved.